Related topics: Globalisation, Commercial Services, Analytical testing, QC, Bulk ingredients, Data management, Phase I-II, Phase III-IV, Preclinical, Supply chain, logistics
Eli Lilly has taken an expansive approach to outsourcing, adding an agreement with Thermo Fisher to its raft of deals, and this strategy is visualised in an interactive timeline from Outsourcing-Pharma.
Since committing to an outsourcing strategy in December 2007 the big pharma has inked a number of deals spanning clinical trials, active pharmaceutical ingredients (API) and drug discovery.
This strategy, which is among the most expansive in the industry, is visualised below. Move the mouse over an area to show headlines and click on the text bubbles to bring up further information and a link to the complete article.
Copyright - Unless otherwise stated all contents of this web site are © 2012 - William Reed Business Media SAS - All Rights Reserved - Full details for the use of materials on this site can be found in the Terms & Conditions